Drug Profile
Research programme: stromal vascular fraction cell therapies - IntelliCell BioSciences
Alternative Names: Adult autologous vascular fraction cells - Intellicell Biosciences; SVFC - Intellicell BiosciencesLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator IntelliCell BioSciences
- Developer IntelliCell BioSciences; University of Arizona
- Class Cell therapies; Stem cell therapies
- Mechanism of Action Cell replacements; Stem cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Heart failure; Osteoarthritis
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for preclinical development in Heart-failure in USA (Intracardiac, Injection)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Heart-failure in USA (IV)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Osteoarthritis in USA (Intra-articular)